Athanor Capital, LP Sangamo Therapeutics, Inc Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$10.17 - $12.64 $368,642 - $458,174
-36,248 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$9.23 - $18.18 $51,383 - $101,208
5,567 Added 18.14%
36,248 $566,000
Q3 2020

Nov 16, 2020
BUY
$9.38 - $12.48 $287,787 - $382,898
30,681 New
30,681 $290,000

Others Institutions Holding SGMO

# of Institutions
115
Shares Held
56.4M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $294M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email